Insulin Resistance: The 10-Year Silent Progression

Insulin Resistance & Disease: The Hidden Timelines

How Insulin Resistance Quietly Builds Before Many Diseases are Diagnosed

Most chronic diseases do not appear suddenly. They are the visible end-point of a metabolic process that began years — sometimes decades — earlier. Insulin resistance (IR) is the upstream driver. Because IR produces no noticeable symptoms in its early years, the damage accumulates silently. Annual HOMA-IR testing is currently the only reliable way to detect it before the clinical conditions below become established.

Why the delay? The body has enormous compensatory reserves. When cells first become resistant to insulin, the pancreas simply produces more insulin to compensate — sometimes for years. Only when those reserves are exhausted, or when structural damage crosses a clinical threshold, does a diagnosable condition appear. By then, the root cause has typically been present for 5–20 years.

Condition	Why it takes this long to become apparent	Reversibility with VLC diet & Intermittent Fasting
Years 1–3 Early Compensatory Phase Pancreas compensates; HOMA-IR rising but no symptoms yet
Hypertension (early onset)	Hyperinsulinaemia activates the sympathetic nervous system and stimulates sodium retention via RAAS. Blood pressure creeps up gradually over 2–4 years before reaching the 140/90 diagnostic threshold — easily missed without regular monitoring.	Fully Reversible In early-stage IR-driven hypertension, VLC diet and intermittent fasting can normalise BP within 8–16 weeks. Multiple RCTs confirm this, including David Unwin's NHS cohort data.
Elevated Fasting Glucose / Pre-diabetes	Fasting glucose only rises once the liver's insulin-suppression mechanism fails — a late event. For years prior, glucose appears normal while insulin is elevated; the standard NHS fasting glucose test misses this entirely.	Fully Reversible VLC diet removes the primary insulin stimulus. Fasting glucose typically normalises within 4–12 weeks. Intermittent fasting accelerates hepatic insulin sensitivity restoration.
MASLD / Fatty Liver (early)	Excess insulin drives de novo lipogenesis in the liver. Fat accumulates slowly and silently — the liver has no pain receptors. An elevated ALT on a blood test may be the only early signal, and it is rarely interpreted as metabolic.	Fully Reversible Hepatocytes regenerate readily. Liver fat typically reduces by 30–50% within 8 weeks of VLC diet. Full resolution of early MASLD is well documented within 3–6 months.
Dyslipidaemia (raised triglycerides)	Insulin resistance impairs lipoprotein lipase, allowing VLDL triglycerides to accumulate. The pattern — high TG, low HDL, small dense LDL — develops over 2–4 years before crossing diagnostic thresholds, and is routinely misattributed to dietary fat intake.	Fully Reversible Triglycerides are among the most responsive markers to VLC diet — often halving within 4–8 weeks. HDL rises in parallel. This is one of the fastest and most reliable responses to dietary carbohydrate restriction.
Years 4–6 Structural Damage Phase Organ-level changes begin; still largely subclinical but increasingly measurable
Type 2 Diabetes	Beta-cell exhaustion is a gradual process. The pancreas can produce 2–4× normal insulin for years before burnout begins. HbA1c only enters the diabetic range once roughly 50% of beta-cell function is lost — typically 5–10 years after IR onset.	Largely Reversible Early T2DM (under 5–6 years duration) is highly reversible. DiRECT trial: 46% in full remission at 1 year. VLC diet removes the insulin burden and allows beta-cell recovery. Longer duration reduces but does not eliminate reversibility.
ADHD (worsening) / Brain Fog	Chronic hyperinsulinaemia suppresses dopamine synthesis and receptor density gradually. Neurological effects accumulate over years; the person typically attributes cognitive changes to stress, age, or overwork rather than a metabolic cause.	Substantially Reversible Dopamine receptor upregulation follows IR reversal within weeks to months. Cognitive improvement and reduced distractibility are commonly reported within the first 90 days of VLC diet and fasting. Some neuroplasticity limits apply in long-standing cases.
IBS / Intestinal Permeability	IR-driven systemic inflammation progressively degrades tight junctions in the gut wall over 3–6 years. Symptoms are intermittent and attributed to food intolerances, stress, or lifestyle — rarely recognised as metabolic in origin by conventional GI medicine.	Highly Reversible The gut wall has one of the highest cell turnover rates in the body. VLC diet removes fermentable substrates and reduces intestinal inflammation. GAPS protocol directly targets gut wall repair. Substantial improvement typically seen within 8–12 weeks.
Asthma (IR-driven)	Insulin resistance promotes airway inflammation via IL-4, IL-5, and IL-13 pathways. Bronchial hyperresponsiveness builds gradually and is typically attributed to allergen exposure, masking the metabolic driver. Adipose-derived leptin compounds the airway inflammation.	Partially Reversible Reducing systemic inflammation through VLC diet demonstrably reduces frequency and severity of attacks. Airway structural remodelling from long-standing disease limits full reversal, but metabolic management significantly reduces medication dependence.
Early AMD / Drusen Formation	IR drives VEGF overexpression and AGE accumulation in Bruch's membrane over years before drusen become visible on retinal imaging. The retina is highly metabolically active and accumulates damage silently; most people have no visual symptoms until intermediate AMD.	Partially Reversible Removing the IR stimulus can halt drusen accumulation and may allow partial clearance via restored RPE autophagy. VLC diet and intermittent fasting address all four mechanistic AMD pathways. Structural damage already incurred is not reversed.
Years 7–10+ Established Disease Phase Clinical diagnoses typically appear here; root cause often decades old by this point
Arthritis (Osteo & Rheumatoid)	IR-driven chronic low-grade inflammation gradually degrades synovial tissue and cartilage. Cartilage has no blood supply and repairs extremely slowly. Joint changes accumulate over 7–15 years before pain is severe enough to prompt investigation and diagnosis.	Partially Reversible Systemic inflammation is highly responsive to VLC diet — C-reactive protein and IL-6 typically fall substantially within 8–12 weeks. Established cartilage loss and joint structural changes cannot be fully reversed, but disease progression can be halted and pain significantly reduced.
OCD / Anxiety Disorders	Disruption of serotonin and GABA pathways by chronic neuroinflammation and gut dysbiosis builds over years. OCD is rarely recognised as having a metabolic component; the neurological changes manifest gradually and are attributed entirely to psychological or genetic causes.	Substantially Reversible Gut-brain axis restoration via VLC and GAPS diet restores serotonin precursor availability and reduces neuroinflammation. Clinical improvements in OCD symptom severity have been documented. Neuroplasticity-dependent timescale: 3–12 months.
Multiple Sclerosis (progressive)	IR-driven neuroinflammation and mitochondrial dysfunction in oligodendrocytes accumulates over 10–20 years before significant demyelination triggers symptoms. Genetic susceptibility determines which individuals cross the threshold; IR is increasingly understood as a major modifiable environmental driver.	Progression Protectable Existing myelin damage is not reversed. However, VLC diet (particularly ketogenic) demonstrably reduces neuroinflammation and may slow progression significantly. Neuroprotective effects of ketosis on oligodendrocyte survival are the subject of current RCTs.
Stroke (ischaemic)	IR-driven hypertension, endothelial dysfunction, and atherosclerosis accumulate over 10–20 years. A stroke typically occurs at a single point in time — but that moment is the culmination of two decades of vascular damage. The root cause is rarely addressed post-event.	Prevent / Protect Brain tissue destroyed by ischaemia is not recovered. However, reversing IR dramatically reduces recurrence risk by addressing endothelial dysfunction, hypertension, and coagulation abnormalities simultaneously. Post-stroke IR reversal is one of the most important interventions possible.
Alzheimer's Disease / Cognitive Decline	Neuronal insulin resistance (now termed Type 3 Diabetes by some researchers) impairs glucose uptake in the brain for 15–25 years before dementia symptoms appear. Amyloid plaque accumulation begins decades before diagnosis. Conventional medicine has no early detection equivalent to HOMA-IR.	Early: Reversible · Late: Protect Pre-symptomatic and MCI stages: VLC diet and intermittent fasting restore brain ketone metabolism, reduce neuroinflammation, and have shown cognitive improvement in several RCTs including Bredesen Protocol outcomes. Established dementia: progression can be slowed; existing neuronal loss is not reversed.

The common thread across all three phases: In every case above, the conditions listed are not random misfortunes. They are predictable downstream expressions of a single upstream metabolic defect — chronically elevated insulin driving inflammation, oxidative stress, and progressive organ-specific damage. The only variable is which organ system is most constitutionally vulnerable in a given individual. This is why HOMA-IR testing — not fasting glucose, not HbA1c — is the critical early-detection tool. It measures the upstream cause directly, years or decades before any of these conditions appear on a standard blood test.

What annual HOMA-IR testing changes: A HOMA-IR score above 1.5 — years before any diagnosable condition appears — signals that the compensatory phase is under way. This is the window of maximum reversibility. Every condition in the Years 1–3 and Years 4–6 bands above is highly tractable at this stage. A very low carbohydrate diet, intermittent fasting, and GAPS gut protocol address the root cause directly. The conditions in the Years 7–10+ band represent what happens when that window closes undetected. The difference between "fully reversible" and "protect remaining function" is almost always a matter of when the upstream cause was identified.

Key Sources Supporting These Timelines

Lean et al. (2018) — DiRECT Trial · The Lancet, 391(10120), 541–551
Primary RCT demonstrating T2DM remission through dietary intervention; establishes the reversibility timeline for early-stage Type 2 Diabetes used in the Years 4–6 band.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)33102-1/fulltext

Hirode & Wong (2020) — Prevalence of Metabolic Syndrome in the US · JAMA, 323(24), 2526–2528
NHANES data establishing the rising prevalence of insulin resistance and metabolic syndrome from 1988–2016; underpins the population-level IR timeline data.
https://jamanetwork.com/journals/jama/fullarticle/2767497

Reaven (1988) — Role of Insulin Resistance in Human Disease · Diabetes, 37(12), 1595–1607
The foundational paper establishing insulin resistance as the upstream driver of hypertension, dyslipidaemia, and glucose dysregulation — basis for the Years 1–3 compensatory phase.
https://diabetesjournals.org/diabetes/article/37/12/1595/8400

Unwin et al. (2019) — Low Carbohydrate Diet to Achieve Weight Loss and Improve HbA1c · BJGP Open, 3(2)
NHS GP cohort data showing blood pressure and glucose normalisation within weeks of VLC diet; supports the Years 1–3 reversibility claims for hypertension and pre-diabetes.
https://bjgpopen.org/content/3/2/bjgpopen19X101539

Chiu et al. (2007) — Dietary Glycaemic Index and Carbohydrate in Relation to AMD · Am J Clin Nutr, 86(1), 180–188
AREDS cohort study linking high glycaemic diet to AMD progression over 5 years; basis for the AMD reversibility and timeline claims in the Years 4–6 band.
https://academic.oup.com/ajcn/article/86/1/180/4633139

Bredesen et al. (2016) — Reversal of Cognitive Decline in Alzheimer's Disease · Aging, 8(6), 1250–1258
Reports cognitive improvement in early Alzheimer's/MCI using metabolic interventions including ketogenic diet and fasting; basis for the Years 7–10+ Alzheimer's reversibility claims.
https://www.aging-us.com/article/101166/text

de Heredia et al. (2012) — Obesity, Inflammation and the Immune System · Proc Nutr Soc, 71(2), 332–338
Reviews the IR-driven inflammatory cascade underpinning arthritis, asthma, and OCD neuroinflammation timelines; supports the structural damage phase claims.
https://www.cambridge.org/core/journals/proceedings-of-the-nutrition-society/article/obesity-inflammation-and-the-immune-system/

Volek & Phinney (2011) — The Art and Science of Low Carbohydrate Living · Beyond Obesity LLC
Comprehensive review of VLC diet effects on triglycerides, HDL, VLDL, and hepatic fat; basis for the dyslipidaemia and MASLD reversibility timelines in Years 1–3.
ISBN: 978-0983490708

Year ranges are indicative and reflect population-level epidemiological data. Individual progression depends on constitutional factors, dietary patterns, activity levels, and genetic predisposition. HOMA-IR = Homeostatic Model Assessment of Insulin Resistance. VLC = Very Low Carbohydrate diet (under 20–50g net carbohydrates per day). Reversibility ratings based on published intervention literature including DiRECT trial (Lean et al. 2018), AREDS dietary cohort (Chiu et al. 2007), Bredesen Protocol cognitive outcomes, David Unwin NHS hypertension cohort data, and Kaarniranta et al. (2020) retinal IR review.